Premium
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Technical considerations and the learning curve
Author(s) -
Vining Charles C.,
Izquierdo Francisco,
Eng Oliver S.,
Turaga Kiran K.
Publication year - 2020
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.25939
Subject(s) - hyperthermic intraperitoneal chemotherapy , medicine , cytoreductive surgery , learning curve , intraperitoneal chemotherapy , chemotherapy , surgery , general surgery , cancer , ovarian cancer , management , economics
Abstract Over the past decade, there has been a considerable increase in the utilization of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of patients with peritoneal metastases. This is due to improved safety and favorable oncologic outcomes, including curative potential. CRS/HIPEC has a steep learning curve and requires familiarity with peritonectomy procedures. This review will outline the technical aspects and learning curve of CRS/HIPEC.